Differentially activated B cells develop regulatory phenotype and show varying immunosuppressive features: a...

Area of Science:

• Immunology
• Cell Therapy
• Immunosuppression

Background:

• Regulatory B lymphocytes (Bregs) possess immunosuppressive properties beneficial for treating immune-related disorders.
• Current adoptive cell therapy using Bregs is limited by low cell numbers and poor survival rates in vitro.
• Generating Bregs ex vivo from peripheral blood CD19+ cells offers a promising alternative for increased cell yield.

Purpose of the Study:

• To investigate efficient in vitro methods for differentiating primary B cells into immunosuppressive regulatory B lymphocytes (Bregs).
• To compare the efficacy of various stimulation cocktails in generating functional Bregs for potential therapeutic use.

Main Methods:

• Primary B cells were stimulated ex vivo using combinations of CD40L, CpG, IL4, IL21, PMA, and ionomycin.
• Functional assays were performed to assess the immunosuppressive capacity of the generated B cells.
• Comparative analysis of different stimulation protocols to identify the most effective method.

Main Results:

• The combination of CD40L, CpG, and IL21 proved most effective in inducing a suppressive phenotype in B cells.
• This specific treatment resulted in the generation of functionally active regulatory B lymphocytes (Bregs).
• The CD40L + CpG + IL21 protocol demonstrated high capacity for inducing immunosuppressive Bregs ex vivo.

Conclusions:

• The CD40L + CpG + IL21 stimulation cocktail is a highly effective method for generating immunosuppressive Bregs ex vivo.
• This approach enhances the potential for using expanded Bregs in adoptive cell therapy for immune-related diseases.
• Optimized ex vivo generation of Bregs can overcome limitations associated with low cell numbers and survival in primary cultures.